BEP Regimen (bleomycin/etoposide/cisplatin)
Multiple manufacturers (component drugs) · Combination Chemotherapy Regimen — Germ Cell Tumors
What is BEP Regimen? BEP (Bleomycin, Etoposide, Cisplatin) is the standard first-line chemotherapy regimen for advanced germ cell tumors (testicular cancer). It achieves high cure rates even in metastatic disease, making testicular cancer one of the most chemotherapy-responsive solid tumors.
About BEP Regimen
| Brand Name | BEP Regimen |
| Generic / INN | bleomycin/etoposide/cisplatin |
| Drug Class | Combination Chemotherapy Regimen — Germ Cell Tumors |
| Manufacturer | Multiple manufacturers (component drugs) |
| Administration | Intravenous (IV) infusion |
| FDA Approval | Components individually FDA-approved; BEP is a well-established clinical regimen |
FDA-Approved Uses
- Advanced germ cell tumors (testicular cancer) — disseminated, good and intermediate risk
- Ovarian germ cell tumors — advanced
- Extragonadal germ cell tumors
How Does BEP Regimen Work?
BEP combines three mechanisms: Bleomycin (DNA strand breaks via reactive oxygen species), Etoposide (topoisomerase II inhibitor), and Cisplatin (DNA crosslinks). Together they produce synergistic cytotoxicity in germ cell tumors, which are highly sensitive to platinum-based chemotherapy.
Dosage & Administration
Standard BEP: Bleomycin 30 units IV days 1, 8, 15; Etoposide 100 mg/m² IV days 1–5; Cisplatin 20 mg/m² IV days 1–5. Repeat every 21 days for 3–4 cycles. Pulmonary function must be monitored due to bleomycin toxicity.
Dosing is individualized by the treating oncologist. Do not adjust without medical guidance. This page is educational only.
Warnings & Side Effects
- Bleomycin pulmonary toxicity — potentially fatal
- Cisplatin nephrotoxicity — hydration essential
- Ototoxicity — may be irreversible
- Avoid high FiO2 with bleomycin (post-op O2 risk)
- Embryo-fetal toxicity
Common Side Effects
- Nausea/vomiting
- Alopecia
- Peripheral neuropathy
- Myelosuppression
- Raynaud's phenomenon
- Ototoxicity
- Renal toxicity
- Bleomycin fever
Storage & Handling
Each component stored separately per prescribing information.
💰 Medication Cost & Insurance Coverage
Approximate Wholesale Acquisition Cost (WAC / List Price)
~$500–$2,000/cycle
3 generic components
Insurance & Prior Authorization
BEP Regimen requires prior authorization from all major insurance plans. BiologicHealthPlus handles the full PA process — clinical documentation, peer-to-peer reviews, and appeals — at no cost to patients or providers.
Prior Authorization Guide Patient Assistance Insurance & Savings
Frequently Asked Questions — BEP Regimen
BEP (Bleomycin + Etoposide + Cisplatin) is the standard first-line regimen for advanced testicular (germ cell) cancer. Even in metastatic disease, BEP achieves cure rates of 70-80%+ in good-risk patients.
High oxygen concentrations (FiO2) during anesthesia can catastrophically accelerate bleomycin-induced lung toxicity. Patients who have received bleomycin must inform anesthesiologists — low FiO2 anesthesia protocols are required.
Good-risk disease: 3 cycles BEP. Intermediate/poor-risk: 4 cycles BEP or alternative regimens. IGCCCG risk classification guides this decision.
Related Medications & Conditions
Related Medications
Cisplatin · Etoposide · Bleomycin · EP regimen (etoposide + cisplatin) · TIP/VIP regimens (second-line)
Related Conditions
Testicular cancer (germ cell tumors) · Ovarian germ cell tumors · Extragonadal germ cell tumors